CSL Limited
CSL
Helyezés a részvények között
#362
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Részvényárfolyam
$138.58
Piaci kapitalizáció
$66.50B
Változás (1 nap)
0.72%
Változás (1 év)
-2.29%
Ország
AU
Kereskedés CSL Limited (CSL)
Kategória
Healthcare
CSL Limited (CSL) osztaléktörténete
CSL Limited (részvényszimbólum: CSL) összesen 64 osztalékfizetést hajtott végre.
Az összes osztalék összege (részvényszétválásokhoz igazítva): $40.42
Osztalékhozam (TTM): 0.0217
Az összes osztalék összege (részvényszétválásokhoz igazítva): $40.42
Osztalékhozam (TTM): 0.0217
CSL Limited (CSL) osztalékfizetései 1994 és 2026 között
Éves osztalékfizetések
| Év | Osztalék (részvényszétválással korrigálva) | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $1.85 | -59.20% |
| 2025 | $4.52 | 13.84% |
| 2024 | $3.97 | 9.48% |
| 2023 | $3.63 | 14.09% |
| 2022 | $3.18 | 8.25% |
| 2021 | $2.94 | -0.07% |
| 2020 | $2.94 | 10.65% |
| 2019 | $2.66 | 16.41% |
| 2018 | $2.28 | 30.24% |
| 2017 | $1.75 | 3.04% |
| 2016 | $1.70 | 3.50% |
| 2015 | $1.64 | 32.85% |
| 2014 | $1.24 | 17.12% |
| 2013 | $1.06 | 27.28% |
| 2012 | $0.83 | 3.75% |
| 2011 | $0.8 | 0.00% |
| 2010 | $0.8 | 14.29% |
| 2009 | $0.7 | 52.17% |
| 2008 | $0.46 | 32.72% |
| 2007 | $0.3466 | 52.96% |
| 2006 | $0.2266 | 151.78% |
| 2005 | $0.09 | -28.97% |
| 2004 | $0.1267 | 11.83% |
| 2003 | $0.1133 | 0.00% |
| 2002 | $0.1133 | 30.68% |
| 2001 | $0.0867 | 13.04% |
| 2000 | $0.0767 | 9.57% |
| 1999 | $0.07 | 16.67% |
| 1998 | $0.06 | 16.28% |
| 1997 | $0.0516 | 18.89% |
| 1996 | $0.0434 | 8.50% |
| 1995 | $0.04 | 139.52% |
| 1994 | $0.0167 | 0.00% |
Az összes osztalékfizetés listája
| Év | Osztalék | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $1.85 | -59.20% |
| 2025 | $4.52 | 13.84% |
| 2024 | $3.97 | 9.48% |
| 2023 | $3.63 | 15.74% |
| 2022 | $3.14 | 6.70% |
| 2021 | $2.94 | -0.07% |
| 2020 | $2.94 | 10.65% |
| 2019 | $2.66 | 16.41% |
| 2018 | $2.28 | 30.24% |
| 2017 | $1.75 | 3.04% |
| 2016 | $1.70 | 3.50% |
| 2015 | $1.64 | 32.85% |
| 2014 | $1.24 | 17.12% |
| 2013 | $1.06 | 27.28% |
| 2012 | $0.83 | 2.66% |
| 2011 | $0.8085 | -1.55% |
| 2010 | $0.8212 | 17.31% |
| 2009 | $0.7 | 52.17% |
| 2008 | $0.46 | -60.27% |
| 2007 | $1.16 | 70.28% |
| 2006 | $0.68 | 144.96% |
| 2005 | $0.2776 | -26.95% |
| 2004 | $0.38 | 11.76% |
| 2003 | $0.34 | 0.00% |
| 2002 | $0.34 | 30.77% |
| 2001 | $0.26 | 13.04% |
| 2000 | $0.23 | 9.52% |
| 1999 | $0.21 | 16.67% |
| 1998 | $0.18 | 16.13% |
| 1997 | $0.155 | 19.23% |
| 1996 | $0.13 | 8.33% |
| 1995 | $0.12 | 140.00% |
| 1994 | $0.05 | 0.00% |
Hasonló cégek vagy versenytársak osztalékfizetései
| Vállalat | Osztalékfizetések száma | Ország |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
|
| 29.00% |
BE
|
